EPSTEIN-BARR VIRUS-POSITIVE BURKITTS-LYMPHOMA CELLS NOT RECOGNIZED BY VIRUS-SPECIFIC T-CELL SURVEILLANCE

[1] PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS [J]. CELL, 1978, 14 (01) : 9 - 20

[2] HUMAN C-MYC ONC GENE IS LOCATED ON THE REGION OF CHROMOSOME-8 THAT IS TRANSLOCATED IN BURKITT-LYMPHOMA CELLS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (24): : 7824 - 7827

[3] EPSTEIN-BARR VIRUS-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T AS PROBES OF HLA POLYMORPHISM - HETEROGENEITY OF T-CELL-RESTRICTING DETERMINANTS ASSOCIATED WITH THE SEROLOGICALLY DEFINED HLA-A2 ANTIGEN [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (02) : 280 - 293

[4] KLEIN G, 1980, CANCER-AM CANCER SOC, V45, P2486, DOI 10.1002/1097-0142(19800515)45:10<2486::AID-CNCR2820451005>3.0.CO

[5] 2-#

[6] RELEASE OF INFECTIOUS EPSTEIN-BARR VIRUS BY TRANSFORMED MARMOSET LEUKOCYTES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (01) : 190 - 194

[7] A COMPARISON OF EPSTEIN-BARR VIRUS-SPECIFIC T-CELL IMMUNITY IN MALARIA-ENDEMIC AND MALARIA-NONENDEMIC REGIONS OF PAPUA-NEW-GUINEA [J]. INTERNATIONAL JOURNAL OF CANCER, 1983, 31 (06) : 727 - 732

[8] RICKINSON AB, 1981, CANCER RES, V41, P4216

[9] MONOCLONAL-ANTIBODY TO HUMAN ACUTE LYMPHOBLASTIC-LEUKEMIA ANTIGEN [J]. NATURE, 1980, 283 (5747) : 583 - 585

[10] PAIRED EPSTEIN-BARR VIRUS-CARRYING LYMPHOMA AND LYMPHOBLASTOID CELL-LINES FROM BURKITTS-LYMPHOMA PATIENTS - COMPARATIVE SENSITIVITY TO NON-SPECIFIC AND TO ALLO-SPECIFIC CYTO-TOXIC RESPONSES INVITRO [J]. INTERNATIONAL JOURNAL OF CANCER, 1984, 34 (03) : 339 - 348

[1] PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS [J]. CELL, 1978, 14 (01) : 9 - 20

[2] HUMAN C-MYC ONC GENE IS LOCATED ON THE REGION OF CHROMOSOME-8 THAT IS TRANSLOCATED IN BURKITT-LYMPHOMA CELLS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (24): : 7824 - 7827

[3] EPSTEIN-BARR VIRUS-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T AS PROBES OF HLA POLYMORPHISM - HETEROGENEITY OF T-CELL-RESTRICTING DETERMINANTS ASSOCIATED WITH THE SEROLOGICALLY DEFINED HLA-A2 ANTIGEN [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (02) : 280 - 293

[4] KLEIN G, 1980, CANCER-AM CANCER SOC, V45, P2486, DOI 10.1002/1097-0142(19800515)45:10<2486::AID-CNCR2820451005>3.0.CO

[5] 2-#

[6] RELEASE OF INFECTIOUS EPSTEIN-BARR VIRUS BY TRANSFORMED MARMOSET LEUKOCYTES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (01) : 190 - 194

[7] A COMPARISON OF EPSTEIN-BARR VIRUS-SPECIFIC T-CELL IMMUNITY IN MALARIA-ENDEMIC AND MALARIA-NONENDEMIC REGIONS OF PAPUA-NEW-GUINEA [J]. INTERNATIONAL JOURNAL OF CANCER, 1983, 31 (06) : 727 - 732

[8] RICKINSON AB, 1981, CANCER RES, V41, P4216

[9] MONOCLONAL-ANTIBODY TO HUMAN ACUTE LYMPHOBLASTIC-LEUKEMIA ANTIGEN [J]. NATURE, 1980, 283 (5747) : 583 - 585

[10] PAIRED EPSTEIN-BARR VIRUS-CARRYING LYMPHOMA AND LYMPHOBLASTOID CELL-LINES FROM BURKITTS-LYMPHOMA PATIENTS - COMPARATIVE SENSITIVITY TO NON-SPECIFIC AND TO ALLO-SPECIFIC CYTO-TOXIC RESPONSES INVITRO [J]. INTERNATIONAL JOURNAL OF CANCER, 1984, 34 (03) : 339 - 348